Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurberry Regulatory News (BRBY)

Share Price Information for Burberry (BRBY)

Share Price is delayed by 15 minutes
Get Live Data
1,137.50    20.50 (1.84%)
Bid:
1,129.50
Ask:
1,132.50
Spread: 3.00 (0.266%)
Market Cap: £4.09b
BRBY Live PriceLast checked at - London Stock Exchange

Intraday Burberry Share Chart

Agreement

3 Apr 2017 10:00

RNS Number : 3467B
Burberry Group PLC
03 April 2017
 

3 April 2017

 

 

Burberry Group plc

 

Burberry announces strategic partnership with Coty for its Beauty business

 

Burberry announces a strategic partnership with Coty to accelerate the growth and development of its Beauty business. The exclusive licensing agreement will take effect from October 2017, subject to regulatory approvals.

 

This follows the successful repositioning and elevation of the Burberry Beauty business over the last four years of direct operation. During this time, Burberry has launched award-winning luxury fragrances such as My Burberry and Mr Burberry, redeveloped and relaunched make-up, and boosted sales of new fragrances in key markets.

 

Leveraging the strengths of each partner, Burberry will lead on creative elements of the Beauty business, while benefitting from Coty's deep beauty industry expertise and first-class global distribution.

 

Christopher Bailey, Chief Creative and Chief Executive Officer of Burberry Group plc, commented:

 

"We are delighted to partner with Coty, a world leader in luxury fragrance and make-up. Working with a global partner of their scale and expertise will help drive the next phase of Burberry Beauty's development and position this business for future growth. Further, the combination of the upfront payments and ongoing royalties is financially attractive and is expected to provide an accretive impact to our earnings from FY 2018/19."

 

Camillo Pane, Chief Executive Officer of Coty Inc., commented:

 

"We are proud to welcome Burberry as a strategic partner of Coty. We look forward to growing further Burberry's luxury beauty products using Coty's world-class expertise in developing and bringing to market beauty brands."

 

 

The information communicated herein is inside information.

 

 

Financial information:

· In the second half of FY 2017/18, Burberry expects to receive cash payments of £130m for the long-term exclusive global licence and related transfer of the Beauty business, and c.£50m for assets transferring (which is subject to inventory adjustments) totalling c.£180m

· Burberry will also receive ongoing royalty payments from October 2017

· Burberry currently expects this agreement to be broadly neutral to adjusted profit before tax* in the transition year (FY 2017/18) and accretive from FY 2018/19

· As part of this agreement c.£50m of gross assets will transfer to Coty, subject to inventory adjustments

· The cash proceeds received will be used for general corporate purposes

· Burberry currently expects c.£30m of one-off cash costs associated with this agreement 

· In FY 2015/16 retail/wholesale Beauty revenue was £203m, the majority of which was wholesale

· All of the above is subject to final regulatory approval and based on currently available information

 

*Adjusting items are defined in note 2 to the financial statements contained in the Annual Report 2015/16.

 

 

Enquiries

 

Investors and analysts

Charlotte Cowley

VP, Investor Relations

020 3367 3524

 

Media

Andrew Roberts

VP, Corporate Relations

020 3367 3764

Caroline Daniel

Paul Raeburn

Brunswick

020 7404 5959

 

About Coty Inc.

· Coty Inc. is one of the world's largest beauty companies with approximately $9 billion in revenue

· Coty's strong entrepreneurial heritage has created an iconic portfolio of leading beauty brands

· Part of the S&P 500, Coty is a global leader in fragrance, professional salon hair colour & styling and colour cosmetics

· Coty's Luxury division is focused on prestige fragrances and skincare with brands such as Calvin Klein, Marc Jacobs, Hugo Boss, Gucci and philosophy

· Coty was founded in 1904

· Visit www.coty.com for further information

 

 

About Burberry

· Established in 1856, Burberry is a global British luxury brand with a heritage of innovation, craftsmanship and design

· The Burberry business comprises 5 divisions: mens, womens, childrens, accessories and beauty

· Burberry is headquartered in London and listed on the London Stock Exchange. Burberry is a constituent of the FTSE 100 index (BRBY.L)

· Visit www.burberry.com for further information

 

 

Certain statements made in this announcement are forward-looking statements. Such statements are based on current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from any expected future results in forward-looking statements. Burberry Group plc undertakes no obligation to update these forward-looking statements and will not publicly release any revisions it may make to these forward-looking statements that may result from events or circumstances arising after the date of this document. Nothing in this announcement should be construed as a profit forecast. All persons, wherever located, should consult any additional disclosures that Burberry Group plc may make in any regulatory announcements or documents which it publishes. All persons, wherever located, should take note of these disclosures. This announcement does not constitute an invitation to underwrite, subscribe for or otherwise acquire or dispose of any Burberry Group plc shares, in the UK, or in the US, or under the US Securities Act 1933 or in any other jurisdiction.

 

BURBERRY, the Equestrian Knight Device and the Burberry Check are trademarks belonging to Burberry which are registered and enforced worldwide.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRDMGGDRFKGNZG
Date   Source Headline
10th Jun 20264:52 pmRNSDirector Declaration
9th Jun 202611:30 amRNSHolding(s) in Company
1st Jun 202610:15 amRNSIssue of Shares & Total Voting Rights
28th May 202610:45 amRNSAnnual Financial Report
14th May 20267:01 amRNSBoard changes
14th May 20267:00 amRNSBurberry FY26 Preliminary Results
1st May 202612:20 pmRNSIssue of Shares & Total Voting Rights
29th Apr 20262:45 pmRNSDirector Declaration
10th Apr 20263:40 pmRNSHolding(s) in Company
9th Apr 202611:30 amRNSHolding(s) in Company
1st Apr 20265:30 pmRNSIssue of Shares & Total Voting Rights
1st Apr 202612:15 pmRNSHolding(s) in Company
20th Mar 202612:31 pmRNSDirector/PDMR Shareholding
20th Mar 202610:25 amRNSIssue of Equity
19th Mar 20266:00 pmRNSHolding(s) in Company
5th Mar 20264:40 pmRNSHolding(s) in Company
2nd Mar 202611:00 amRNSTotal Voting Rights
12th Feb 20262:00 pmRNSHolding(s) in Company
10th Feb 202610:30 amRNSHolding(s) in Company
2nd Feb 20262:00 pmRNSTotal Voting Rights
27th Jan 20265:00 pmRNSHolding(s) in Company
22nd Jan 202612:30 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSThird Quarter Trading Update
9th Jan 202612:30 pmRNSHolding(s) in Company
2nd Jan 202611:30 amRNSTotal Voting Rights
18th Dec 20252:01 pmRNSHolding(s) in Company
18th Dec 20252:01 pmRNSHolding(s) in Company
12th Dec 20259:15 amRNSDirector/PDMR Shareholding
2nd Dec 20255:40 pmRNSHolding(s) in Company
1st Dec 20251:30 pmRNSTotal Voting Rights
24th Nov 20255:30 pmRNSHolding(s) in Company
20th Nov 20254:20 pmRNSHolding(s) in Company
19th Nov 20255:36 pmRNSHolding(s) in Company
18th Nov 20256:07 pmRNSHolding(s) in Company
13th Nov 20255:27 pmRNSHolding(s) in Company
13th Nov 20257:00 amRNSBurberry Interim Results
3rd Nov 20252:43 pmRNSTotal Voting Rights
28th Oct 20254:50 pmRNSHolding(s) in Company
15th Oct 20255:38 pmRNSHolding(s) in Company
10th Oct 202512:07 pmRNSHolding(s) in Company
2nd Oct 20253:10 pmRNSHolding(s) in Company
1st Oct 202510:30 amRNSTotal Voting Rights
25th Sep 20256:00 pmRNSHolding(s) in Company
5th Sep 20256:21 pmRNSBlock listing Interim Review
5th Sep 20255:45 pmRNSDirector/PDMR Shareholding
1st Sep 202512:14 pmRNSTotal Voting Rights
13th Aug 20253:04 pmRNSHolding(s) in Company
1st Aug 202511:58 amRNSTotal Voting Rights
31st Jul 20254:55 pmRNSDirector/PDMR Shareholding
18th Jul 20255:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.